Journal of Oncology Practice, Vol 2, No 6 (November), 2006: pp. 263
© 2006
American Society of Clinical Oncology.
DOI: 10.1200/JOP.2.6.263
Who Will Tailor Therapy?
Douglas W. Blayney, MD
| Because this article has no abstract, we have provided an extract of the first 100 words of the full text.
|
| |
Douglas W. Blayney, MD
|
|
Here is a business opportunity: Someone will devise a business (perhaps not in the profit-making sense, but in the organizational sense) to streamline the value chain that results in therapy specifically tailored to your patients and their tumor. Though oncologists have tailored targeted therapy for over 30 years, we are at the tail end of a disorganized, haphazard value chain to deliver this service.
This value chain starts with the decision regarding source and timing of obtaining a tissue sample, continues with patient preparation and with procuring and processing the specimen, and finally, with interpreting the . . . [Click for More]
|